Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 26.06 CNY 1.16%
Market Cap: 10.9B CNY
Section:
 

Relative Value

The Relative Value of one Liaoning Chengda Biotechnology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 26.06 CNY, Liaoning Chengda Biotechnology Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Liaoning Chengda Biotechnology Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

7.2
P/S
P/S
Price to Sales
7.2
vs History
50
vs Industry
71
Median 3Y
7.1
Median 5Y
7.3
Industry
8
Forward
4.3
More Details
44.3
P/E
P/E
Price to Earnings
44.3
vs History
11
vs Industry
10
Median 3Y
28.1
Median 5Y
26.8
Industry
23.5
Forward
12.2
More Details
23
P/OCF
P/OCF
Price to OCF
23
vs History
32
vs Industry
14
Median 3Y
21.6
Median 5Y
21.6
Industry
21.9
More Details
112.6
P/FCFE
P/FCFE
Price to FCFE
112.6
vs History
39
vs Industry
5
Median 3Y
107.5
Median 5Y
103.5
Industry
24.3
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
81
vs Industry
70
Median 3Y
1.2
Median 5Y
1.3
Industry
3.2
More Details
7.2
EV/S
EV/S
Enterprise Value to Sales
7.2
vs History
15
vs Industry
84
Median 3Y
4.5
Median 5Y
4.5
Industry
8.1
Forward
4.3
More Details
9.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.1
vs History
9
vs Industry
84
Median 3Y
5.4
Median 5Y
5.4
Industry
10.1
More Details
46.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
46.2
vs History
5
vs Industry
30
Median 3Y
14.2
Median 5Y
14.2
Industry
5.9
Forward
8.8
More Details
46.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
46.2
vs History
5
vs Industry
28
Median 3Y
14.2
Median 5Y
14.2
Industry
6.2
Forward
11.1
More Details
23
EV/OCF
EV/OCF
Enterprise Value to OCF
23
vs History
15
vs Industry
31
Median 3Y
12.9
Median 5Y
12.9
Industry
7.7
More Details
112.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
112.7
vs History
20
vs Industry
26
Median 3Y
67.6
Median 5Y
67.3
Industry
6.3
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
84
vs Industry
74
Median 3Y
1.4
Median 5Y
1.6
Industry
5.6
More Details

Multiples Across Competitors

Competitors Multiples
Liaoning Chengda Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
10.8B CNY 7.2 44.3 46.2 46.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 865 457.5 -160 957.5 -195 453.7 -193 223.4
US
Abbvie Inc
NYSE:ABBV
389.1B USD 6.5 165.7 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
172.5B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
146.9B USD 5.1 18.1 12.1 12.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114B USD 9.7 31 22.7 23.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 080.3 -530.8 -578 -562.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD 5.6 17.6 16.7 19
AU
CSL Ltd
ASX:CSL
81.7B AUD 3.5 18.3 12.4 15.5
NL
argenx SE
XBRU:ARGX
41.8B EUR 13.6 32 54.8 56.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 203.5 162.3 196.8
P/E Multiple
Earnings Growth PEG
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Average P/E: 172.8
44.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 957.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.6
10%
1.8
AU
CSL Ltd
ASX:CSL
18.3
11%
1.7
NL
argenx SE
XBRU:ARGX
32
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 203.5
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Average EV/EBITDA: 40.1
46.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 453.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.1
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.7
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
11%
1.5
AU
CSL Ltd
ASX:CSL
12.4
8%
1.5
NL
argenx SE
XBRU:ARGX
54.8
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.3
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Average EV/EBIT: 45.6
46.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 223.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.1
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.7
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -562.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
13%
1.5
AU
CSL Ltd
ASX:CSL
15.5
11%
1.4
NL
argenx SE
XBRU:ARGX
56.3
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.8
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.